Product: ALPROSTADIL  10MCG/ML INJECTABLE 10 ML, 20 ML, 3 ML, 30 ML, 5 ML, 6 ML; ALPROSTADIL  15MCG/ML INJECTABLE 5 ML; ALPROSTADIL  20MCG/ML INJECTABLE 10 ML, 10 MLS, 20 ML, 3 ML, 30 ML, 4 ML, 40 ML, 5 ML, 6 ML; ALPROSTADIL  24MCG/ML INJECTABLE 6 ML; ALPROSTADIL  25MCG/ML INJECTABLE 10 ML; ALPROSTADIL  30MCG/ML INJECTABLE 10 ML; ALPROSTADIL  35MCG/ML INJECTABLE 10 ML; ALPROSTADIL  40MCG/ML INJECTABLE 10 ML, 10 ML, 10 VIAL, 15 ML, 2 ML, 20 ML, 3 ML, 30 ML, 40 ML, 5 ML, 50 ML, 6 ML; ALPROSTADIL  50MCG/ML 
Reason for recall: Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Recall initiated: 20120525
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated